ACLS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Glenner, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Glenner, G.
Annals of Clinical and Laboratory Science, Vol 5, Issue 4, 257-263
Copyright © 1975 by Association of Clinical Scientists


Articles

Current concepts of the formation and composition of amyloid

GG Glenner

Immunochemical and chemical studies of purified amyloid fibril protein from a wide variety of human tissues reveals that amyloid fibrils may derive from immunoglobulin proteins most frequently in the "primary" disease and can be classified as of kappa- or lambda-type. In addition a protein of unknown origin is the source of amyloid fibrils in another group of cases usually of "secondary" type. The creation of fibrils with all the characteristics of amyloid fibrils has been accomplished by proteolysis of some Bence Jones proteins. This indicates that amyloid fibrils may be formed by proteolytic digestion of circulating light polypeptide chains of immunoglobulin proteins.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1975 by the Association of Clinical Scientists.